Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

59.66 -3.58 (-5.66%)
Streaming Delayed Price Updated: 9:50 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Exact Sciences Cor

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The 3 Best Cathie Wood Stocks to Buy in April 2024
Cathie Wood doesn't have a great overall record, but she sometimes makes great picks. Here are the three best Cathie Wood stocks to buy now. 
Via InvestorPlace
1 Beaten-Down Cathie Wood Stock to Buy and Hold
This company is innovating where it matters most, which could prove highly lucrative down the road. 
Via The Motley Fool
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
The companies are working to detect colon cancer and precancerous markers in blood and/or stool. 
Via Investor's Business Daily
ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
(EXAS) - Analyzing Exact Sciences's Short Interest
Via Benzinga
2 Beaten-Down Cathie Wood Stocks With Massive Potential
They won't lag the market forever. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat... 
Via Benzinga
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
3 Growth Stocks to Buy at 52-Week Lows in March
Wager on these growth stocks to buy at 52-week lows offering robust investment potential ahead for savvy investors. 
Via InvestorPlace
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
Earnings Preview For Exact Sciences
Via Benzinga
Cathie Wood Is Selling This Stock: Should You?
This company hasn't performed well in the past 12 months. 
Via The Motley Fool
Cathie Wood Darling Exact Sciences Could Pop After Its Next-Gen Product Outperforms
Exact Sciences is hoping to launch an next-generation version of Cologuard in 2025. 
Via Investor's Business Daily
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the... 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Stable Stocks to Buy for 100% Returns by 2025
If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks. 
Via InvestorPlace
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential. 
Via InvestorPlace
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript
EXAS earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said. 
Via Benzinga
Topics Economy
Exposures Interest Rates
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
--News Direct-- 
Via News Direct
Topics Death
Exposures Death
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
The global population is experiencing a scary increase in colorectal cancer, especially among young people. Colorectal cancer (CRC) diagnoses have been steadily rising since the 1990s; in 1995 the... 
Via Benzinga
Topics Death
Exposures Death
3 Stocks to Buy for the Age of Personalized Medicine
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider. 
Via InvestorPlace
2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul
These stocks can reward patient investors. 
Via The Motley Fool
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now. 
Via InvestorPlace
Cathie Wood's Ark Invest Acquires Over $25.5 Million Worth Of Tesla Shares — Sells Coinbase And Robinhood Stock A Day After Bitcoin Spot ETF Approval
On Thursday, Cathie Wood-led Ark Invest made a significant move in the stock market, purchasing $25.55 million worth of shares in Tesla Inc (NASDAQ:TSLA). 
Via Benzinga
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.